EN | UA
EN | UA

Help Support

Back

Dextrose gel reduces hypoglycemic episodes in newborn nursery

Hypoglycemia Hypoglycemia
Hypoglycemia Hypoglycemia

To examine the efficacy of oral Dextrose gel (DG) 40% for managing neonatal hypoglycemia. 

See All

Key take away

Oral Dextrose gel improves neonatal care by lowering the incidences of multiple hypoglycemic episodes (the most common metabolic condition in newborns).

Background

To examine the efficacy of oral Dextrose gel (DG) 40% for managing neonatal hypoglycemia. 

Method

This study reviewed medical records of 738 at-risk infants in two groups: one before (Cohort 1) and one after (Cohort 2) the use of 40% DG orally. The main outcome was two or more episodes of hypoglycemia in infants. The average glucose levels and admission to the NICU were secondary outcomes.

Result

In Cohort 1, there were 384 at-risk newborns, and in Cohort 2, there were 354. Following DG implementation, the incidence of experiencing two or more hypoglycemia episodes decreased significantly (62 versus 29). There were no significant differences found in the lowest recorded glucose levels (37 (14-45) versus 37 (10-45)) or in NICU admission rates (21.2% versus 18.8%).

Conclusion

DG reduces the occurrence of subsequent hypoglycemia episodes in newborn children.

Source:

Official journal of the California Perinatal Association

Article:

The impact of implementation of oral dextrose gel on the incidence of multiple hypoglycemia events in the well newborn nursery

Authors:

Lakshmy Vaidyanathan et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru
Try: